← FDA Drug Approvals (Drugs@FDA)
ERLOTINIB HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2019-11-05
Drug application
- FDA Application #
ANDA210300- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERLOTINIB HYDROCHLORIDE
- Generic name
- ERLOTINIB
- Active ingredients
- ERLOTINIB HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SUN PHARM
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- First approval
- 2019-11-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown